Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

Similar articles for PubMed (Select 24560748)

1.

Depiction of celiac ganglia on positron emission tomography and computed tomography in patients with lung cancer.

Abtahi SM, Elmi A, Hedgire SS, Ho YC, Pourjabbar S, Singh S, Kalra M, Harisinghani M.

Clin Imaging. 2014 May-Jun;38(3):292-5. doi: 10.1016/j.clinimag.2013.12.017. Epub 2014 Jan 6.

PMID:
24560748
2.

A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.

Kauhanen SP, Komar G, Seppänen MP, Dean KI, Minn HR, Kajander SA, Rinta-Kiikka I, Alanen K, Borra RJ, Puolakkainen PA, Nuutila P, Ovaska JT.

Ann Surg. 2009 Dec;250(6):957-63. doi: 10.1097/SLA.0b013e3181b2fafa.

PMID:
19687736
3.

[18F]FDG positron emission tomography/computed tomography and multidetector computed tomography roles in thymic lesion treatment planning.

Travaini LL, Petralia G, Trifirò G, Ravasi L, Galetta D, Carbone G, Falcini F, Spaggiari L, Bellomi M, Paganelli G.

Lung Cancer. 2008 Sep;61(3):362-8. doi: 10.1016/j.lungcan.2008.01.019. Epub 2008 Mar 20.

PMID:
18358558
4.

Pulmonary mucosa-associated lymphoid tissue lymphoma: computed tomography and ¹⁸F fluorodeoxyglucose-positron emission tomography/computed tomography imaging findings and follow-up.

Zhang WD, Guan YB, Li CX, Huang XB, Zhang FJ.

J Comput Assist Tomogr. 2011 Sep-Oct;35(5):608-13. doi: 10.1097/RCT.0b013e318227a661.

PMID:
21926857
5.

(18)F-FDG PET versus (18)F-FDG PET/CT for adrenal gland lesion characterization: a comparison of diagnostic efficacy in lung cancer patients.

Sung YM, Lee KS, Kim BT, Choi JY, Chung MJ, Shim YM, Yi CA, Kim TS.

Korean J Radiol. 2008 Jan-Feb;9(1):19-28. doi: 10.3348/kjr.2008.9.1.19.

6.

Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.

Kanzaki R, Higashiyama M, Maeda J, Okami J, Hosoki T, Hasegawa Y, Takami M, Kodama K.

Interact Cardiovasc Thorac Surg. 2010 Jun;10(6):1009-14. doi: 10.1510/icvts.2009.227538. Epub 2010 Mar 2.

7.

Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions?

Casneuf V, Delrue L, Kelles A, Van Damme N, Van Huysse J, Berrevoet F, De Vos M, Duyck P, Peeters M.

Acta Gastroenterol Belg. 2007 Oct-Dec;70(4):331-8.

PMID:
18330088
8.

Accuracy of multi-detector computed tomography, fluorodeoxyglucose positron emission tomography-CT, and CA 19-9 levels in detecting recurrent pancreatic adenocarcinoma.

Hamidian Jahromi A, Sangster G, Zibari G, Martin B, Chu Q, Takalkar A, Shi R, Shokouh-Amiri H.

JOP. 2013 Jul 11;14(4):466-8. doi: 10.6092/1590-8577/1529.

9.

Impact of computed tomography and 18F-deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non-small-cell lung cancer.

Deniaud-Alexandre E, Touboul E, Lerouge D, Grahek D, Foulquier JN, Petegnief Y, Grès B, El Balaa H, Keraudy K, Kerrou K, Montravers F, Milleron B, Lebeau B, Talbot JN.

Int J Radiat Oncol Biol Phys. 2005 Dec 1;63(5):1432-41. Epub 2005 Aug 25.

PMID:
16125870
10.

Fluorodeoxyglucose positron emission tomography with computed tomography detects greater metabolic changes that are not represented by plain radiography for patients with osteonecrosis of the jaw.

Fleisher KE, Raad RA, Rakheja R, Gupta V, Chan KC, Friedman KP, Mourtzikos KA, Janal M, Glickman RS.

J Oral Maxillofac Surg. 2014 Oct;72(10):1957-65. doi: 10.1016/j.joms.2014.04.017. Epub 2014 Apr 24.

PMID:
25053572
11.

Diagnostic accuracy of 18F-2-deoxy-fluoro-D-glucose positron emission tomography for pN1 lymph nodes in patients with lung cancer.

Nakagawa M, Hara M, Sakurai K, Ozawa Y, Mizuno A, Tamaki T, Nishio M, Shibamoto Y.

Acta Radiol. 2009 Jul;50(6):638-44. doi: 10.1080/02841850902971255.

PMID:
19492198
12.

Fluorodeoxyglucose-positron-emission tomography/computed tomography imaging for adrenal masses in patients with lung cancer: review and diagnostic algorithm.

Stone WZ, Wymer DC, Canales BK.

J Endourol. 2014 Jan;28(1):104-11. doi: 10.1089/end.2013.0380. Epub 2013 Oct 9. Review.

13.

Dual-tracer PET/CT imaging in evaluation of metastatic hepatocellular carcinoma.

Ho CL, Chen S, Yeung DW, Cheng TK.

J Nucl Med. 2007 Jun;48(6):902-9. Epub 2007 May 15.

14.

[The application of 18F-fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer].

Xu HF, Liu Y, Zhang JH, Zhou RS, Zhou FH, Yuan MH.

Zhonghua Jie He He Hu Xi Za Zhi. 2005 Feb;28(2):108-11. Chinese.

PMID:
15854393
15.

Dynamic MRI, dynamic multidetector-row computed tomography (MDCT), and coregistered 2-[fluorine-18]-fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET)/CT: comparative study of capability for management of pulmonary nodules.

Ohno Y, Koyama H, Takenaka D, Nogami M, Maniwa Y, Nishimura Y, Ohbayashi C, Sugimura K.

J Magn Reson Imaging. 2008 Jun;27(6):1284-95. doi: 10.1002/jmri.21348.

PMID:
18504748
16.

Clinical significance of intrathoracic lesions detected by 18F-fluorodeoxyglucose positron emission tomography in the management of patients with head and neck cancer.

Roh JL, Ryu CH, Kim JS, Lee JS, Choi SH, Nam SY, Kim SY.

Oral Oncol. 2007 Sep;43(8):757-63. Epub 2006 Nov 16.

PMID:
17112773
17.

High performance of F-fluorodeoxyglucose positron emission tomography and contrast-enhanced CT in a rapid outpatient diagnostic program for patients with suspected lung cancer.

Brocken P, van der Heijden HF, Dekhuijzen PN, Peters-Bax L, de Geus-Oei LF.

Respiration. 2014;87(1):32-7. doi: 10.1159/000347096. Epub 2013 Apr 16.

PMID:
23595051
18.

Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging.

Shim SS, Lee KS, Kim BT, Chung MJ, Lee EJ, Han J, Choi JY, Kwon OJ, Shim YM, Kim S.

Radiology. 2005 Sep;236(3):1011-9. Epub 2005 Jul 12.

PMID:
16014441
19.

Role of 18F-fluorodeoxyglucose positron emission tomography in predicting epidermal growth factor receptor mutations in non-small cell lung cancer.

Mak RH, Digumarthy SR, Muzikansky A, Engelman JA, Shepard JA, Choi NC, Sequist LV.

Oncologist. 2011;16(3):319-26. doi: 10.1634/theoncologist.2010-0300. Epub 2011 Feb 21.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk